This current research looks at how patients with alexithymia's general self-efficacy is affected by cognitive-behavioral group therapy. Using a multi-group pre-test-post-test design with control and follow-up groups, the research's methodology was quasi-experimental. All of the alexithymia patients who received referrals to the Shahid Rajaei Medical Center in Tehran during the second half of 2020 made up the statistical population for the research. Two groups of fifteen individuals each comprised the statistical sample for the research (15 individuals in the experimental group and 15 individuals in the control group). They were divided into two experimental and control groups at random after being carefully chosen. The Toronto Alexithymia Scale and the General Self-Efficacy Scale (GSE-10) were used to gather data. Both univariate and multivariate analysis of covariance tests were employed to examine the data. The outcomes showed that patients with alexithymia can benefit from cognitive-behavioral group treatment in terms of their overall self-efficacy (P<0.05).
|